Stocks and Investing Stocks and Investing
Mon, July 1, 2024
Fri, June 28, 2024

Ami Fadia Reiterated (BPMC) at Strong Buy and Held Target at $130 on, Jun 28th, 2024


Published on 2024-10-28 12:10:36 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Reiterated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $130 on, Jun 28th, 2024.

Ami has made no other calls on BPMC in the last 4 months.



There are 10 other peers that have a rating on BPMC. Out of the 10 peers that are also analyzing BPMC, 3 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Berens of "Leerink Partners" Upgraded from Sell to Hold and Increased Target to $97 on, Monday, May 6th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $104 on, Friday, May 3rd, 2024
  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $75 on, Friday, May 3rd, 2024


These are the ratings of the 7 analyists that currently disagree with Ami


  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $125 on, Friday, June 7th, 2024
  • Sudan Loganathan of "Stephens & Co." Initiated at Buy and Held Target at $140 on, Tuesday, May 14th, 2024
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $168 on, Monday, May 6th, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Friday, May 3rd, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $76 on, Friday, May 3rd, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024
Contributing Sources